Characterization & Treatment of Chronic Pain After Moderate to Severe TBI
Public ClinicalTrials.gov record NCT03739307. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Characterization & Treatment of Chronic Pain After Moderate to Severe Traumatic Brain Injury
Study identification
- NCT ID
- NCT03739307
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Craig Hospital
- Other
- Enrollment
- 3,805 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 19, 2019
- Primary completion
- Sep 30, 2022
- Completion
- Sep 30, 2022
- Last update posted
- Feb 7, 2023
2019 – 2022
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | — |
| Craig Hospital | Englewood | Colorado | 80113 | — |
| Tampa VA | Tampa | Florida | 33612 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Spaulding Rehabilitation Institute | Charlestown | Massachusetts | 02129 | — |
| Wayne State University | Detroit | Michigan | 78202 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| New York University School of Medicine | New York | New York | 10016 | — |
| MOSS Rehabilitation Research Institute | Elkins Park | Pennsylvania | 19027 | — |
| Baylor Research Institute | Dallas | Texas | 75204 | — |
| TIRR Memorial Hermann | Houston | Texas | 77030 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| University of Washington | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03739307, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 7, 2023 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03739307 live on ClinicalTrials.gov.